1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The National Center for Advancing Translational Sciences Clinical and Translational Science Awards (CTSA) is a grant from the Department of Health and Human Services that funds academic health centers and research institutions to build and sustain infrastructure for translational research. The CTSA program accelerates the process of turning scientific discoveries into new treatments and interventions that improve human health.
Eligible applicants include domestic institutions of higher education, universities, academic health centers, medical research institutions, and nonprofit research organizations. Recent federal obligations suggest approximately $99. 6 million in awards for 2026.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
National Center for Advancing Translational Sciences U.S. Department of Health & Human Services National Institutes of Health More Treatments for All People More Quickly We conduct research and support activities that address long-standing challenges in translational research so that new treatments and other health solutions reach people faster.
Read our latest research news or follow coverage of our translational science activities through national and local media. How NCATS Is Accelerating Drug Discovery: A Behind-the-Scenes Look With NIH Leadership April 16, 2026 - NCATS News Our Impact on Drug Discovery and Development NIH senior leadership toured NCATS’ laboratories to learn how the center supports innovative technology to model human disease and explores drug repurposing.
WEST AI Algorithm May Help Speed Diagnosis of Rare Diseases WEST AI Algorithm May Help Speed Diagnosis of Rare Diseases April 14, 2026 - NCATS News Clinical and Translational Science Awards (CTSA) Program Our Impact on Rare Diseases Rare diseases can take years to diagnose. WEST — a new AI algorithm — aims to cut that diagnostic odyssey by learning from complete and incomplete real-world EHR data.
Neuroimmune Signaling Between the Heart and the Brain May Contribute to Heart Attack Damage Neuroimmune Signaling Between the Heart and the Brain May Contribute to Heart Attack Damage April 10, 2026 - NCATS News Clinical and Translational Science Awards (CTSA) Program NIH-funded researchers found a harmful triple-node loop involved in heart attacks.
Blocking any one of these three components reduced heart injury and improved heart function.
Rare Disease Day at NIH 2026: Paving the Way to a Brighter Future for All Americans Rare Disease Day at NIH 2026: Paving the Way to a Brighter Future for All Americans March 31, 2026 - NCATS News Our Impact on Rare Diseases The rare diseases community came together at the NIH Natcher Conference Center and virtually to celebrate Rare Disease Day at NIH, highlighting inspiring stories, impactful research advances, and new possibilities for the future.
April NIH/NCATS N3C Community Forum The National Clinical Cohort Collaborative (N3C) Community Forum will convene virtually on Monday, April 27, from 4 to 5 p. m. EDT.
During the Forum, NCATS’ N3C Team will discuss N3C governance, review progress and procedures, and answer questions from the community. Please register today to join us on April 27 at 4 p. m.
EDT. Advancing Translational Science Learn how our work speeds research and improves health. Key areas include big data , clinical trials and rare diseases .
Explore our research labs, projects and collaborations that are advancing translational science. Our largest program is the Clinical and Translational Science Awards (CTSA) Program . Enhance your knowledge of translational science through programs, activities and resources offered by NCATS and our partner institutions .
Whether you're a researcher, an aspiring translational scientist or an interested member of the community, find information and materials important to you. Learn about our latest opportunities for funding and collaboration and connect with our staff. Learn about the resources and support available to help you grow as a translational scientist.
For Patients and Advocates Learn about the patient-focused research and resources available through NCATS and NIH. NCATS Director Roundtable Supporters, researchers and educators will hear the latest updates from NCATS Director Dr. Rutter and can participate in an interactive discussion as we work together to bring more treatments to all people more quickly. Joni L.
Rutter, Ph. D. , is the director of NCATS at NIH.
Rutter oversees the planning and execution of NCATS complex, multifaceted programs. Search all Director's Messages by topic and year. Last updated on April 10, 2026
According to the current listing, eligibility includes: The CTSA application may include domestic institutions of higher education, universities, medical research institutions / academic health centers, or non-profit research organizations other than institutions of higher e…. Confirm the full requirements in the official notice before applying.
The current listing shows recent federal obligations suggest $99,590,982 (2026). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Yes — National Center for Advancing Translational Sciences - Clinical and Translational Science Awards is offered by Department of Health And Human Services and this listing comes from SAM.gov, an official U.S. federal source. Federal applications generally require registrations (for example SAM.gov or an agency submission portal), so allow extra lead time.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Research Infrastructure Programs - Research Centers is sponsored by Department of Health And Human Services. The Office of Research Infrastructure Programs (ORIP), within the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) in the NIH Office of the Director, supports extramural biomedical research by strengthening the infrastructure that enables scientific discovery. ORIP advances human health by fostering the development of critical research models, biomaterials, and technologies; expanding access to state-of-the-art instrumentation and facilities; supporting education and training programs; and assisting small businesses in translating innovative technologies. Through its two divisions, the Division of Comparative Medicine (DCM) and the Division of Construction and Instruments (DCI), ORIP plays a critical role in accelerating biomedical research nationwide. DCM develops and sustains essential research models and biological resources, manages the infrastructure required for their use and distribution, and provides training to ensure investigators have reliable access to high-quality models and facilities. DCI supports shared, cost-effective access to advanced scientific instrumentation, modernizing research facilities, and providing critical equipment that enables transformative biomedical discoveries. Together, DCM and DCI strengthen U.S. competitiveness and ensure the biomedical research community has the infrastructure necessary to address emerging health challenges, prevent disease, promote health, and advance foundational science. This listing is currently active. Program number: 93.3RC. Last updated on 2026-01-28.
Research Infrastructure Programs - Construction is sponsored by Department of Health And Human Services. The Office of Research Infrastructure Programs (ORIP), within the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) in the NIH Office of the Director, supports extramural biomedical research by strengthening the infrastructure that enables scientific discovery. ORIP advances human health by fostering the development of critical research models, biomaterials, and technologies; expanding access to state-of-the-art instrumentation and facilities; supporting education and training programs; and assisting small businesses in translating innovative technologies. Through its two divisions, the Division of Comparative Medicine (DCM) and the Division of Construction and Instruments (DCI), ORIP plays a critical role in accelerating biomedical research nationwide. DCM develops and sustains essential research models and biological resources, manages the infrastructure required for their use and distribution, and provides training to ensure investigators have reliable access to high-quality models and facilities. DCI supports shared, cost-effective access to advanced scientific instrumentation, modernizing research facilities, and providing critical equipment that enables transformative biomedical discoveries. Together, DCM and DCI strengthen U.S. competitiveness and ensure the biomedical research community has the infrastructure necessary to address emerging health challenges, prevent disease, promote health, and advance foundational science. This listing is currently active. Program number: 93.CN1. Last updated on 2026-01-28.
The STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read articleThe Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read article